CC
PRME icon

Corsicana & Co’s Prime Medicine PRME Stock Holding History

Corsicana & Co’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$3.47K – 281
2025
Q4 		$3.47K Hold
1,000
– – ﹤0.01% 229
2025
Q3 		$5.54K Buy
+1,000
New +$4.06K ﹤0.01% 206

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Corsicana & Co's PRME Position: Q1 2026 in Review

Corsicana & Co sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 1,000 shares — an estimated $3.47K sold.

Corsicana & Co first reported a position in PRME in Q3 2025 and held it in 2 quarters. The position peaked at $5.54K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Corsicana & Co reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Corsicana & Co sold 1,000 Prime Medicine shares in Q1 2026, an estimated $3.47K.
  • Corsicana & Co first reported a position in Prime Medicine in Q3 2025 and held it in 2 quarters.
  • Corsicana & Co's Prime Medicine position peaked at $5.54K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Corsicana & Co's 13F filing for Q1 2026, filed 13 May 2026.